InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Litvack Frank, Director. Director active across 1 company, notably Capricor Therapeutics, INC.. Cumulatively, 4 filings have been logged. History available since 3 January 2022. The latest transaction was filed on 13 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
3,937 shares@ US$1.390.0003% mcap1.2% of flowCommon StockSEC:0001310715-26-000004:0
3,937 shares@ US$1.392.4% of flowCommon StockSEC:0001310715-26-000004
154,543 shares@ US$1.3997.6% of flowCommon StockSEC:0001415889-22-000284
154,543 shares@ US$1.390.011% mcap48.8% of flowCommon StockSEC:0001415889-22-000284:0
4 of 4 declarations
About Litvack Frank
Frank Litvack is a Board Member of Capricor Therapeutics, Inc., a biotechnology company. As a board member, he participates in overseeing the company's activities and making strategic decisions. His expertise in the biotechnology field is valuable for guiding Capricor's initiatives.
